Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Cystatin C Assay Market, by Region, 2020-2030 (USD Million)
1.2.2. Cystatin C Assay Market, by Product, 2020-2030 (USD Million)
1.2.3. Cystatin C Assay Market, by Method, 2020-2030 (USD Million)
1.2.4. Cystatin C Assay Market, by Sample Type, 2020-2030 (USD Million)
1.2.5. Cystatin C Assay Market, by Application, 2020-2030 (USD Million)
1.2.6. Cystatin C Assay Market, by End-user, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cystatin C Assay Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cystatin C Assay Market Dynamics
3.1. Cystatin C Assay Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Supportive government policies
3.1.1.2. Rising incidences of chronic kidney diseases and increasing aging population
3.1.2. Market Challenges
3.1.2.1. High development costs of cystatin C assays
3.1.2.2. Stringent requirements for approval of cystatin C assay instruments and consumables
3.1.3. Market Opportunities
3.1.3.1. Increasing adoption of point of care testing
3.1.3.2. Rising focus on the development of condition-specific biomarkers and tests
Chapter 4. Global Cystatin C Assay Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cystatin C Assay Market, by Product
5.1. Market Snapshot
5.2. Global Cystatin C Assay Market by Product, Performance - Potential Analysis
5.3. Global Cystatin C Assay Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Cystatin C Assay Market, Sub Segment Analysis
5.4.1. Analyzers
5.4.2. Kits
5.4.3. Reagents
Chapter 6. Global Cystatin C Assay Market, by Method
6.1. Market Snapshot
6.2. Global Cystatin C Assay Market by Method, Performance - Potential Analysis
6.3. Global Cystatin C Assay Market Estimates & Forecasts by Method 2020-2030 (USD Million)
6.4. Cystatin C Assay Market, Sub Segment Analysis
6.4.1. Enzyme-Linked Immunosorbent Assay (ELISA)
6.4.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
6.4.3. Particle-enhanced Nephelometric Immunoassay (PENIA)
6.4.4. Chemiluminescent immunoassay (CLIA)
6.4.5. Immunofluorescence assay (IFA)
6.4.6. Others
Chapter 7. Global Cystatin C Assay Market, by Sample Type
7.1. Market Snapshot
7.2. Global Cystatin C Assay Market by Sample Type, Performance - Potential Analysis
7.3. Global Cystatin C Assay Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
7.4. Cystatin C Assay Market, Sub Segment Analysis
7.4.1. Blood
7.4.2. Urine
Chapter 8. Global Cystatin C Assay Market, by Application
8.1. Market Snapshot
8.2. Global Cystatin C Assay Market by Application, Performance - Potential Analysis
8.3. Global Cystatin C Assay Market Estimates & Forecasts by Application 2020-2030 (USD Million)
8.4. Cystatin C Assay Market, Sub Segment Analysis
8.4.1. Diagnostics
8.4.2. Research
Chapter 9. Cystatin C Assay Market, by End-user
9.1. Market Snapshot
9.2. Global Cystatin C Assay Market by End-user, Performance - Potential Analysis
9.3. Global Cystatin C Assay Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
9.4. Cystatin C Assay Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Clinical Laboratories
9.4.3. Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes
Chapter 10. Global Cystatin C Assay Market, Regional Analysis
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Cystatin C Assay Market, Regional Market Snapshot
10.4. North America Cystatin C Assay Market
10.4.1. U.S. Cystatin C Assay Market
10.4.1.1. Product breakdown estimates & forecasts, 2020-2030
10.4.1.2. Method breakdown estimates & forecasts, 2020-2030
10.4.1.3. Sample Type breakdown estimates & forecasts, 2020-2030
10.4.1.4. Application breakdown estimates & forecasts, 2020-2030
10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Cystatin C Assay Market
10.5. Europe Cystatin C Assay Market Snapshot
10.5.1. U.K. Cystatin C Assay Market
10.5.2. Germany Cystatin C Assay Market
10.5.3. France Cystatin C Assay Market
10.5.4. Spain Cystatin C Assay Market
10.5.5. Italy Cystatin C Assay Market
10.5.6. Rest of Europe Cystatin C Assay Market
10.6. Asia-Pacific Cystatin C Assay Market Snapshot
10.6.1. China Cystatin C Assay Market
10.6.2. India Cystatin C Assay Market
10.6.3. Japan Cystatin C Assay Market
10.6.4. Australia Cystatin C Assay Market
10.6.5. South Korea Cystatin C Assay Market
10.6.6. Rest of Asia Pacific Cystatin C Assay Market
10.7. Latin America Cystatin C Assay Market Snapshot
10.7.1. Brazil Cystatin C Assay Market
10.7.2. Mexico Cystatin C Assay Market
10.8. Middle East & Africa Cystatin C Assay Market
10.8.1. Saudi Arabia Cystatin C Assay Market
10.8.2. South Africa Cystatin C Assay Market
10.8.3. Rest of Middle East & Africa Cystatin C Assay Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Abbott (US)
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Roche Diagnostics Limited (Switzerland)
11.3.3. Siemens Healthineers AG(Germany)
11.3.4. Thermo Fisher Scientific Inc. (US)
11.3.5. Randox Laboratories Ltd. (UK)
11.3.6. DiaSys Diagnostic Systems GmbH (Germany)
11.3.7. Bio-Techne (US)
11.3.8. Gentian Diagnostics ASA (Norway)
11.3.9. Getein Biotech, Inc. (China)
11.3.10. Agilent Technologies, Inc. (US)
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption